Data companies band together to form RWE Alliance
Can an industry coalition help craft policy to support the use of Real-World Evidence? Five prominent real-world data and analytics companies are betting on it, launching the RWE Alliance.
Can an industry coalition help craft policy to support the use of Real-World Evidence? Five prominent real-world data and analytics companies are betting on it, launching the RWE Alliance.
In a wide-ranging interview, Maggie Huston, associate general counsel for precision medicine company Tempus, discusses how to balance innovation with safety as the FDA grapples with AI/ML and new, more complex technology, as well how her company quickly reacted to Covid-19.
Business may have slowed for many, but several biotech and digital health startups are still bringing in venture capital dollars. Here are a few biotech and healthcare companies that announced funding rounds this week.
The company, which is led by Groupon co-founder Eric Lefkofsky, is focused on the collection and analysis of molecular and clinical data.
The feasibility study was meant to see whether personalized cancer genetic sequencing and drug sensitivity recommendations could be done in a "clinically reasonable amount of time."
In 2018 alone, ten companies have inked mega-deals of more than $100 million including Livongo, 23andMe and American Well.
Called Tempus Labs, the Chicago startup's new tool is currently available and allows physicians to securely access patient information at the point of care.
Why do some patients respond to immuno-oncology drugs when others don’t? Tempus developed a tool to aggregate the phenotypic, therapeutic, and outcome and response data to help physicians answer this question.
The biotechnology company is led by Groupon cofounder and chairman Eric Lefkofsky. The latest round brings the startup's total funding to $130 million.
After a career spent in tech, Eric Lefkofsky's mission took an unexpected twist when his wife was diagnosed with cancer: "I was just amazed at how little technology had permeated her care and I became infatuated with trying to understand why," he said.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.